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Abstract
The envelope (E) protein from coronaviruses is a small polypeptide that contains at least one a-helical transmembrane
domain. Absence, or inactivation, of E protein results in attenuated viruses, due to alterations in either virion morphology or
tropism. Apart from its morphogenetic properties, protein E has been reported to have membrane permeabilizing activity.
Further, the drug hexamethylene amiloride (HMA), but not amiloride, inhibited in vitro ion channel activity of some
synthetic coronavirus E proteins, and also viral replication. We have previously shown for the coronavirus species
responsible for severe acute respiratory syndrome (SARS-CoV) that the transmembrane domain of E protein (ETM) forms
pentameric a-helical bundles that are likely responsible for the observed channel activity. Herein, using solution NMR in
dodecylphosphatidylcholine micelles and energy minimization, we have obtained a model of this channel which features
regular a-helices that form a pentameric left-handed parallel bundle. The drug HMA was found to bind inside the lumen of
the channel, at both the C-terminal and the N-terminal openings, and, in contrast to amiloride, induced additional chemical
shifts in ETM. Full length SARS-CoV E displayed channel activity when transiently expressed in human embryonic kidney 293
(HEK-293) cells in a whole-cell patch clamp set-up. This activity was significantly reduced by hexamethylene amiloride
(HMA), but not by amiloride. The channel structure presented herein provides a possible rationale for inhibition, and a
platform for future structure-based drug design of this potential pharmacological target.
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Introduction
Coronaviruses (family Coronaviridae, genus Coronavirus [1]) are
enveloped viruses that cause common colds in humans and a
variety of lethal diseases in birds and mammals [2–4]. The virus
species in the genus Coronavirus have been organized into 3 groups,
using genetic and antigenic criteria [5]. Group 1 is subdivided into
two groups, 1a and 1b. Group 1a includes the porcine
Transmissible gastroenteritis virus (TGEV), whereas group 1b
includes Human coronaviruses 229E (HCoV-229E) or NL63
(HCoV-NL63). Group 2 is also subdivided in groups 2a, e.g.,
Murine hepatitis virus (MHV) and Human coronavirus OC43
(HCoV-OC43) and 2b, e.g., the virus responsible for the severe
acute respiratory syndrome (SARS-CoV) [6,7]. Group 3 includes
the avian Infectious bronchitis virus (IBV) and the turkey
coronavirus (TCoV).
SARS-CoV produced a near pandemic in 2003 [8], with 8,096
infected cases and 774 deaths worldwide (http://www.who.int/
csr/sarsarchive/2003_05_07a/en/). SARS-CoV was enzootic in
an unknown animal or bird species, probably a bat [9], before
suddenly emerging as a virulent virus in humans. A similar
crossing of the animal-human species barrier is thought to have
occurred between the bovine coronavirus (BCoV) and human
coronavirus OC43 (HCoV-OC43) more than 100 years ago [10].
Such coronavirus interspecies jumps, from animal hosts to
humans, are likely to reoccur in the future.
There is therefore an urgent need to know more about the
coronavirus life cycle, and about new ways to battle infection.
Protective efficacy of candidate vaccines against coronaviruses in
humans has been mainly studied in animals so far, and only few
vaccines have entered Phase 1 human trials [11]. Other
compounds [12–17] have shown activity against SARS-CoV and
HCoV-229E, but there is no data from animal studies or clinical
trials [18]. Studies of antiviral therapy against coronaviruses other
than SARS-CoV have been scarce; in vitro data show that several
chemicals may have inhibitory activities on HCoV-NL63 and
HCoV-229E [19,20], but there have not been clinical trials on
therapy of infections caused by human coronaviruses HCoV-
OC43, HCoV-229E, HCoV-NL63 and HCoV-HKU1.
All coronaviruses express the envelope (E) protein, a typically
short polypeptide that in SARS-CoV is 76 amino acids long, and
which contains at least one a-helical transmembrane domain
(ETM). In SARS-CoV E the transmembrane domain spans ,25
residues [21], approximately from residue 10 to 35. Coronavirus E
proteins are incorporated into the virion lipidic envelope, along
with the spike protein (S) and the membrane protein (M). While
the S protein is involved in fusion with host membranes during
entry into cells, and the M protein is important in envelope
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vivo coronavirus replication. However, its absence results in an
attenuated virus, as shown for SARS-CoV [22]. Recently, using a
transgenic mouse model expressing the SARS-CoV receptor
human angiotensin converting enzyme-2 (hACE-2), SARS
coronavirus lacking gene E was shown to be attenuated and, in
contrast to the wild type virus, did not grow in the central nervous
system [23]. In other coronaviruses, E protein affects viral
morphogenesis, i.e., virus-like particle (VLP) formation and release
[24–29]. Indeed, mutations in the extramembrane domain of E
protein impaired viral assembly and maturation in MHV [30]. In
TGEV, the absence of E protein resulted in a blockade of virus
trafficking in the secretory pathway and prevention of virus
maturation [31,32].
In addition to the aforementioned roles of E protein in
morphogenesis and tropism, enhanced membrane permeability has
been observed in bacterial and mammalian cells expressing MHV E
[33] or SARS-CoV E [34]. It has also been reported that synthetic E
proteins of SARS-CoV, HCoV-229E, MHV, and IBV, have in vitro
cation-selective ion channel activity in planar lipid bilayers, and this
activity has been shown to be localized at the transmembrane domain
[35–37]. It was also shown that the drug hexamethylene amiloride
(HMA), but not amiloride, inhibited in vitroconductance of synthetic
MHV E and HCoV-229E E, and decreased viral replication of
MHV and HCoV-229E in infected cells [36].
To determine if this channel activity is biologically relevant, this
function must be associated to a structural organization compatible
with an ion channel, together with electrophysiological studies
performed using the complete polypeptide. Lastly, a correlation
between inhibition and a molecular description of drug-channel
interaction must be obtained. The data currently available, however,
(see above) was obtained using synthetic transmembrane peptides or
unpurified synthetic E proteins in non-physiological environments
[35–37], or using qualitative permeability assays [33,34], and the
target of HMA was not unequivocally determined [36].
The fact that SARS-CoV ETM forms only pentamers in
dodecylphosphocholine (DPC) and perfluorooctanoic (PFO)
micelles [38], strongly suggests that the ion channel activity of
coronavirus E proteins is caused by a pentameric ion channel.
Therefore, in the present work our aim was (i) to use NMR to
determine the structure of the pentameric oligomer formed by a
selectively labeled SARS-CoV ETM (residues 8 to 38) when
reconstituted in DPC micelles, (ii) to characterize the interaction of
HMA or amiloride with this channel, and (iii) to test if this data is
still relevant in a more physiological environment, using patch
clamped mammalian cells expressing full length SARS-CoV E.
The structural model described for this channel provides a
valuable insight into coronavirus envelope ion channel activity, ion
selectivity and channel inhibition, and could serve as a platform
for the development of novel anti-viral drugs.
Results
3D structure of the ETM channel
The 3D structure of the pentameric channel formed by the
transmembrane domain of SARS-CoV E (ETM) was reconstruct-
ed in several stages (Fig. S1, A–C). In a first stage, the structure of
the ETM monomer was calculated using the constraints derived
from 492 NOEs. For a set of 20 ETM monomeric conformers, the
backbone root-mean-square deviation (RMSD) was less than 1 A ˚,
or 1.5 A ˚ after including side chain heavy atoms (see statistics in
Table S1). ETM forms a continuous a-helix encompassing all
residues (Fig. 1, A–C), including both N- and C-termini, showing
no signs of terminal fraying [39]. Similar results were obtained in
the presence of the drugs HMA and amantadine (AMT) (Fig. S2).
The latter drug was shown to inhibit in vitro channel activity of a
transmembrane domain of SARS-CoV ETM flanked by two N-
and C-terminal lysines [37].
In a second stage, a representative ETM conformer was
selected, and threaded through the pentameric scaffold of ETM
[38,40] while monitoring inter-monomer constraints; out of
possible 9 inter-monomer constraints (Fig. 2), only 5 were finally
used (Table S2). NOEs were added sequentially, and upon
fulfillment of the NOE, the next NOE was added. Ambiguity due
to overlap of resonances from
1H
b2 of L19 and
1H
b2/
1H
c of L21
was resolved by molecular dynamics (MD) and energy minimiza-
tion to adjust side chain orientations of residues forming the inter-
helical interface.
Orientation of ETM determined using paramagnetic
probes and residual dipolar couplings (RDCs)
To validate independently our reconstructed pentameric ETM
model, the orientation of the ETM helices relative to the DPC
molecules in the micelle was determined using ‘‘dipolar waves’’
[41], i.e., oscillations in the longitudinal relaxation of protons due
to the periodically variable proximity of ETM
1H
N to 16-DSA, a
hydrophobic paramagnetic probe confined to the DPC environ-
ment. The observed paramagnetic relaxation enhancement (PRE)
of the six isotopically labeled residues in ETM (Fig. 3A) was
compared with the PRE calculated from our model according to
Protocol S1 (and see Fig. S3). The good fit between observed and
expected values validates the proposed orientation of the ETM
helices in the a-helical bundle. This orientation was further
confirmed by the observed broadening of the NOESY crosspeaks
from aromatic side-chains of F20, F23 and F26 to aliphatic
protons of DPC after addition of 3 mM 16-DSA (not shown).
Cross-peaks from ETM N- and C-terminal residues, E8-T11 and
T35-R38, remained unaffected, indicating that these residues are
exposed to the aqueous environment. Consistent with this, we
observed broadening of NOESY cross-peaks from E8-L12 and
Author Summary
Coronaviruses are viral pathogens that cause a variety of
lethal diseases in birds and mammals, and common colds in
humans. In 2003, however, an animal coronavirus was able
to infect humans and produced severe acute respiratory
syndrome (SARS), causing a near pandemic. Such events are
likely to reoccur in the future, and new antiviral strategies
are necessary. A small coronavirus protein called ‘envelope’
isimportantforpathogenesis, affectingtheformationofthe
viral envelope and the distribution of the virus in the body.
In vitro studies have shown that synthetic coronavirus
envelope proteins have channel activity that in some cases
has been inhibited by the drug hexamethylene amiloride,
but not by amiloride. In the present paper, we have
characterized the structure responsible for this channel
activity. We have also determined the binding site of the
drug hexamethylene amiloride in the channel, and shown
that amiloride has only a mild effect on the NMR signals
from the protein. The validity of these results is supported
using mammalian cells expressing full length SARS-CoV E,
where channel activity was inhibited by hexamethylene
amiloride, but only mildly by amiloride. The structural
model describedfor this channel provides a valuable insight
into coronavirus envelope protein ion channel activity, and
could serve as a platform for the development of novel anti-
viral drugs.
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gadodiamide was added to a fresh sample (not shown).
Residual dipole couplings (RDCs) were also measured (Fig. 3B)
using two different polyacrylamide concentrations and methods of
compression. A 4% gel was subjected to axial compression (its
lower density allows the application of greater compressive forces)
while an 8% gel was subjected to radial compression using a gel
press assembly. In both RDC measurements, a sinusoidal wave of
residue periodicity of ,3.6 could be observed from residues 19 to
25, consistent with a-helical periodicity. The RDC of residue L18
could not be fit to this periodicity, due to either deviation from
ideal a-helical geometry or to conformational dynamics. The
Figure 1. ETM forms a continuous a-helix in DPC micelles. (A) Superimposed 20 conformers of ETM (monomer) calculated from CYANA. The
peptide backbone is shown in cyan and the residue side chains in gold. (B) Secondary structure plot for ETM depicted as bands of varying thickness,
indicative of the NOE intensity. Sequential and medium range NOE connectivities are shown below the primary sequence. dNN amide backbones and
daN(i,i+3), daN(i,i+4) connectivities are mostly continuous throughout the length of the peptide, indicating that the peptides adopt a predominantly a-
helical conformation [71]. (C) Representative H
N/H
N region of 2D NOESY spectra.
doi:10.1371/journal.ppat.1000511.g001
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where one of the tensors coincided with the axis of symmetry of
the helical bundle, consistent with the helix forming part of an
oligomeric complex, as shown previously by other techniques [38].
Thus, to summarize, the present pentameric a-helical bundle
model was built using (i) NOE constraints, (ii) paramagnetic
relaxation data, (iii) the obtained alignment tensor/axis of
symmetry from RDCs, and (iv) the known oligomeric size of the
ETM a-helical bundle.
To gain a further insight on the compactness of the channel
structure, we monitored the deviation of the observed chemical
shifts from those expected in a random coil structure. The
periodicity in these chemical shifts was analyzed using wavelets
(Fig. S4). For residues 8–18 the periodicity was 2.8 residues per
cycle, close to that of a 310 helix (3 residues per turn), for residues
19–30theperiodicitywas6.2,andforresidues32–38the periodicity
was 3.8 residues per cycle, i.e., close to that of a canonical a-helix.
We interpret the low periodicity in the central part of the a-helix as
due to a tighter packing of the oligomer, i.e., lumenally oriented
ETM residues are expected to experience a less hydrophilic
environment in this region than in the less compact ends of ETM,
leading to a more uniform hydrophobicity around the helix.
The lumen of the pentameric ETM assembly (Fig. 4A) adopts a
distinct hour-glass shape. The polar side chains of N15 are
oriented towards the lumen and, from the MD simulations, they
form a ring with an inner diameter of about 4–5 A ˚ (Fig. 4B, C).
The hydrophobic side chains of L18 and A22 line a more spacious
region where the diameter reaches ,7.3 A ˚. The most constricted
part is located between residues V25 and L28 with diameters of
2.0 and 2.3 A ˚, respectively (Fig. 4B, C).
Effect of HMA and amiloride on ETM
It has been reported that the drug HMA, but not amiloride,
inhibited in vitro conductance of synthetic MHV E and HCoV-
229E E [36], which are close homologs to SARS-CoV E.
Therefore, we tested the effects of both drugs on the ETM
channel. When ETM in DPC micelles was exposed to HMA,
changes in
1H
N chemical shift were observed throughout the
peptide, with most affected ETM amide protons clustering at both
ends of ETM, L19 exhibiting the largest chemical shift (Fig. 5A).
The NOEs observed between HMA and ETM (Fig. S5) suggest
the presence of two binding sites, one near R38 and another near
N15. This figure also shows that a protonated form of HMA at
nitrogen-5 is bound to the channel. This form may be stabilized by
Figure 2. Intra- and inter-monomeric NOEs. Dereference 2D homonuclear
1H
N,
1H
aromatic band-selected NOESY exhibiting NOEs between
1H
covalently bound to the
13C spins of L18, L19, and L21 and other proximal
1H spins. Intramonomeric cross-peaks are shown in blue. Cross-peaks
which cannot be explained by intramonomer interactions based on the reconstructed secondary structure are assigned to intermonomer NOEs, and
are shown in red.
doi:10.1371/journal.ppat.1000511.g002
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guanidinium moiety of R38, resulting in an observable
1H
N5 signal
at 10.7 ppm (Table S3). In the absence of ETM, this HMA
resonance was only observed when the pH was lower than 3.5,
indicating a possible role of ETM in the stabilization of this HMA
protonated state.
The relative intensities of the cross-peaks assigned to HMA
protons indicate that at the N-terminal binding site, near N15,
HMA:ETM stoichiometry approaches 1:5, i.e., one HMA
molecule per ETM pentamer. In contrast, at the C-terminal
binding site, near R38, the HMA:ETM stoichiometry was 1:2
suggesting for this site a rapid (in the chemical shift time scale)
exchange between ETM-bound and micelle-bound forms of
HMA. We note that DPC micelles and HMA exhibited identical
diffusion rates, indicating that HMA partitions into the detergent
phase. The shifts in the [
1H,
15N]-HSQC spectrum after addition
of HMA are apparent (Fig. S6, AC). Amiloride, in contrast, did
not produce significant chemical shift changes (Fig. S6, BD), even
at an ETM:drug molar ratio ten times higher than for HMA (not
shown). For comparison, addition of AMT at ten times more
concentration than HMA also produced similar chemical shifts as
those observed for HMA (not shown). However, in contrast to
HMA, no NOEs between AMT and ETM were detected.
It is interesting to note that L19, which was present at a
discontinuity point in chemical shift periodicity (Fig. S4, B), also
showed a significantly broadened cross-peak in the [
1H,
15N]-
HSQC spectrum due to conformation exchange processes. By
elevating the temperature from 30uCt o3 7 uC, this exchange
increased, resulting in sharpening of the L19 cross-peak (Fig. S6,
EF). Broadening was also reduced by addition of HMA at 30uC
(Fig. S6, G), suggesting stabilization of one of the ETM
exchanging conformers by bound HMA. Incidentally, increasing
the temperature from 30uCt o3 7 uC also resulted in sharpening of
the L18 cross-peak (not shown), indicating that both residues may
be involved in a hinge-like motion.
The proposed two binding sites of HMA in the ETM channel
are shown in Fig. 6. In one binding site, HMA may be stabilized
by a hydrogen bonding network to the Asn 15 side chains, with the
cyclohexamethylene ring pointing away from the center of the
channel (Fig. 6, AC). The second binding location for HMA was
observed near the C-terminus of ETM, around residue R38,
where the amiloride group of HMA is likely to be involved in
interactions with the guanidinium groups of R38 (Fig. 6, BD). The
cyclohexamethylene ring was in van der Waals contact with
methyl groups of residue T35, i.e., oriented towards the center of
the membrane.
Electrophysiological measurements
To confirm the relevance of this pentameric structure and the
effect of HMA and amiloride on the channel activity, results were
obtained by transient expression of SARS-CoV E in human
embryonic kidney 293 (HEK-293) cells. Transfected cells pro-
duced significantly higher channel activity than the controls
(Fig. 7A). The whole-cell patch clamp recording (Fig. 7B) reveal
moderate inward (negative current) and large outward (positive
current) conductance. The same figure shows significantly smaller
‘control’ currents obtained with cells transfected with the vector
alone, or non-transfected HEK-293 cells. ACSF (artificial cerebro-
spinal fluid) was used as bath solution, which contained a high
concentration of NaCl (124 mM), whereas the internal solution
contained a high concentration of potassium ion (145 mM), close
to the intracellular medium under physiological conditions. Under
our recording conditions, the estimated equilibrium potentials,
ENa and Ek, were 65 mV and 287 mV, respectively. Strong
selectivity for either of these cations would produce a reversal
potential (i.e., zero current) near their corresponding equilibrium
potential. If the channel was poorly selective, the reversal potential
would have a value somewhere in between ENa and Ek, whereas
no selectivity would produce a reversal potential in the mid point
between these values (,210 mV). The observed value of reversal
potential at ,0 mV (Fig. 7B) indicates low selectivity between
sodium and potassium, with perhaps a mild preference for sodium.
This is consistent with previous results performed in planar lipid
bilayers with synthetic E proteins [35,36].
TotesttheinhibitoryeffectofHMA,cellswereexposedto10 mM
HMA in the bath solution. This significantly reduced the whole cell
current flowing through SARS-CoV E protein; indeed, the mean
peak current at 70 mV was reduced by ,60% (P,0.02, unpaired t-
test) (Fig. 7C). Amiloride, in contrast, reduced the mean peak
current by only ,25%, although this difference was not statistically
significant (P.0.05, unpaired t-test) (Fig. 7D). In this figure, we note
that the peak current for transfected cells recorded in panel B,
,600 pA, is larger than that in panels C and D, of ,200 pA. We
attribute these differences to variation in cDNA preparation,
transfection, and the time of recording following transfection.
Figure 3. Orientation of ETM relative to the detergent phase
and a-helical geometry. (A) PRE rates of
1H
N nuclei for residues A22,
V24, V25, L18, L19 and L21 (black solid line), superimposed to predicted
PRE from the ETM pentamer using either the immersion depth method
(black dotted line) or the distance from the center method (black
dashed line)(Fig. S3, BC). (B) RDCs for
1H
N nuclei corresponding to A22,
V24, V25, L18, L19 and L21 in 4% and 8% polyacrylamide gels
compressed axially (m) or radially (&), respectively. Best-fit sine waves
of 3.6 periodicity (red lines) are superimposed onto both PREs and RDCs
plots, and show that the stretch of residues 19–24 adopt a regular a-
helical structure. The RDCs of flanking residue L18 could not be fitted to
this ,3.6 periodicity, suggesting a local deviation from ideal a-helical
geometry.
doi:10.1371/journal.ppat.1000511.g003
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The ETM pentameric channel
ETM shows a sufficiently resolved
1H NMR spectra. However,
to facilitate resonance assignment and to unequivocally identify
inter-monomer NOEs, six labeled amino acids were chemically
incorporated near the center of the ETM a-helix. Selection of
appropriate specific labels is facilitated by prediction of likely inter-
monomer interactions using other lower resolution biophysical
techniques. In particular, the model reconstructed here with NMR
data is consistent with a model that was derived from the analysis
of evolutionary conservation of ETM in coronavirus envelope
proteins [40]. The latter approach is data independent, and only
relies on the reasonable assumption that all homologues share the
same backbone structure [42]. Because by definition conservative
mutations that appear during evolution should not destabilize the
correct model of transmembrane interaction, but may destabilize
incorrect low energy models that appear during the simulations
along with the correct model, these mutations act effectively as an
in silico filter [43]. The inter-helical orientation obtained for the
ETM a-helices, and their orientation respect to the lumen of the
ETM channel and detergent phase, is also in agreement with
previous ETM helix rotational orientation measurements obtained
by infrared linear dichroism [38].
Ourmodelshowsa 2–2.3 A ˚ wideconstrictionformedbytheside-
chains of V25 and V28. This is probably not wide enough for the
passage of sodium ions, which suggests this represents a closed state
of the ETM channel. The
1H-
15N dipolar couplings from the six
labeled backbone amides exhibited a periodicity of 3.6, consistent
with a canonical a-helical periodicity, except for L18 which was
foundtobe anoutlier,i.e.,its
1H-
15Nvectorpointsina directionnot
consistent with the other labeled residues. Additionally, the amide
groups of L18 and L19 showed significant line broadening, which
was reduced at more elevated temperature likely dueto acceleration
of the exchange rates. We interpret this as a conformational
exchange-induced transverse relaxation at these residues, and we
speculate that these conformational dynamics may be required for
the channel’s function. Similar band narrowing was observed after
addition of the drug HMA (see below).
Ion selectivity of ETM
In a previous report [36], it was suggested that synthetic CoV E
proteins have cation selective channel activity, with selectivity
(PNa/PK) of 0.25 for HCoV-229E, 69 for MHV E, 10 for SARS-
Figure 4. Pentameric structure of ETM. (A) Lumen of the a-helical bundle (blue) formed by the ETM a-helices (omitted for clarity), with most
constricted region at V25 (green). (B) Radius of the lumen of the ETM channel as a function of residue number, calculated by HOLE [66]. (C) Side view
surface representation of the ETM channel showing the lumen volume. Oxygen and nitrogen atoms are colored red and blue respectively.
doi:10.1371/journal.ppat.1000511.g004
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mild preference for sodium over potassium. According to these
data, only the apparent selectivity of HMV for sodium appears to
be significant. The diameter of naked Na
+ is around 2 A ˚, and that
of K
+ is 2.66 A ˚, and the diameter of the ETM pore at the level of
N15 (4 to 5 A ˚) is sufficient to accommodate a single dehydrated
Na
+ or K
+ ion. Hence it may be speculated that N15, or its polar
equivalent in other sequences, form a selectivity filter for cations.
The equivalent residue to SARS-CoV E N15 in MHV E is Gln
(Fig. S7), which has a one methylene longer side chain. This may
lead to further occlusion of the channel at this position, and may
explain the observed higher selectivity for sodium in MHV E. We
also note that the lumen-facing orientation of Asn and Gln may
also have a structural role, as these residues are known to stabilize
transmembrane interactions [44–46].
Inhibition by HMA and binding site in ETM
In the present work, we localized two binding sites for HMA.
We speculate that the localization of HMA near N15 could be
similar in other CoV E proteins because this position (lumen-
exposed) is always occupied by a polar residue in other CoV E
sequences (N, Q, S, T) (Fig. S7). However, HMA sensitivity has
only been shown for E proteins that contain a long polar side chain
at this position, e.g., N (SARS-CoV E (this paper), HCoV-229E
[36]) or Q (MHV E [36]); IBV E, which contains a smaller polar
side chain (Thr) was HMA-insensitive [36]. It would be interesting
to test if E proteins containing a small polar side chain at this
position, e.g., S or T, are generally HMA insensitive.
Similarly, at the C-terminal end of ETM, in the position
equivalent to R38 in SARS-CoV E, a basic residue is often found
in other E sequences (Fig. S7). Additionally, in HMA-sensitive
CoV E proteins, at least one of the lumen-facing residues
immediately below R38 is polar: TA in SARS-CoV E, AS in
MHV E, and KL in HCoV-229E. For IBV E (group 3) which was
reported to be HMA insensitive [36] there is no polar residue at
this position (AF pair). We note, however, that R38 is the C-
terminal residue in ETM, and may not be involved in HMA
binding in the context of the full length protein. Experiments to
clarify this point using an extended ETM or full length SARS-
CoV E are in progress.
For cells infected with MHV, the EC50 for HMA was ,4 mM,
whereas in an E-deleted virus (MHVDE), no effect was observed after
HMA addition, pointing to E protein as the HMA target [36]. HMA
a l s oi n h i b i t e dH C o V - 2 2 9 Er e p l i c a t i o ni nc u l t u r e dc e l l s ,w i t ha nE C 50
of ,1 mM. In neither case, however, did amiloride have antiviral
activity on replication in cultured cells. Consistent with these results,
Figure 5. Chemical shift perturbation in ETM induced by HMA. (A) Difference in the
1H
N chemical shifts (ETM minus ETMHMA) after addition of
HMA at the molar ratio described in Methods. Amides exhibiting deviations of chemical shifts of more than 0.05 ppm are highlighted in green. (B)
Top view of the ETM pentameric model showing these amides as small spheres.
doi:10.1371/journal.ppat.1000511.g005
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expressing SARS-CoV E is inhibited by extracellular HMA, but not
by amiloride, suggesting a specific activity.
SARS-CoV E in plasma membranes is oriented with the N-
terminus facing the cytoplasm [47], whereas the C-terminus of the
ETM would face the extracellular domain. The latter therefore
would be the likely HMA binding site in our patch clamp
experiment, although the fact that HMA partitions into detergent
micelles, and presumably into lipid bilayers, suggests that both N
and C-termini of ETM could be accessible to the drug.
Figure 6. Binding of HMA to the ETM pentameric channel. (A) Side view of the binding of HMA to the ETM pentamer in the vicinity of N15.
The side chains of amino acids interacting with HMA are shown using a stick representation. (B) Binding of HMA to the C-terminal binding site of the
channel, in the vicinity of T35 and R38. The lowest energy conformation of HMA is shown at the centre of bundle. For clarity, one of the ETM
monomers has been removed. (C) and (D), top views of panels (A) and (B), respectively.
doi:10.1371/journal.ppat.1000511.g006
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our NMR data, because addition of amiloride to ETM showed an
increase in line broadening, but only small changes in peak
positions, suggesting a global perturbation of protein structure but
not a specific interaction. Finally, although the chemical shifts
induced by AMT (not shown) were similar to those observed for
HMA, we did not observe NOEs between AMT and ETM. This is
not unexpected; in contrast with what we observed in a lysine-
flanked ETM peptide [37,38], the in vitro ion channel activity
observed for ETM without flanking lysines, i.e., like the one used
herein, was not inhibited by AMT [38].
The flexibility encountered around residues 18–19, which was
reduced by temperature or by addition of HMA, is reminiscent of
the changes observed in the influenza A channel M2 after addition
of AMT. The M2 open state (low pH) has been shown to be
dynamic or heterogeneous [48], as opposed to the less flexible
closed state (high pH). Addition of AMT to M2 caused substantial
narrowing of
15N spectra [48] and a reduced M2 conformational
distribution in a MAS
13C and
15N NMR study [49], both
indicative of a more rigid M2 channel in the presence of the drug.
The latter studies conform to a model where M2 accesses several
conformational states, and AMT would stabilize a ‘closed’
conformation. In SARS-CoV E, a similar rigidization of ETM
may be partly responsible for inhibition, although physical
blockage to ion passage is also possible. A more complete ETM
labeling approach, which is in progress, will undoubtedly shed
more light on the nature of this inhibition.
Effect of extramembrane domain of SARS-CoV E on
stability
Another important issue is the effect of the extramembrane
domain on channel function and stability. For example, in M2
proton channel from influenza A, truncating the cytoplasmic tail
alters ion channel activity when M2 is expressed in oocytes of
Xenopus laevis [50], and analytical ultracentrifugation showed
that the full-length protein stabilizes the M2 tetramer by
Figure 7. Current-voltage relationship of SARS-CoV E protein and inhibition by HMA. (A) Example traces of current flowing through cells
expressing SARS-CoV E protein, vector alone-transfected cells and untransfected HEK-293 cells. The cells were held at 0 mV and stepped to various
potentials from 2100 to 70 mV (in steps of 10 mV). (B) Whole-cell I–V curve in which peak current amplitudes were plotted against test potentials.
Notice the significant large inward and outward currents recorded from SARS-CoV E protein, in contrast to vector alone and untransfected HEK-293
cell controls (*, two-tail unpaired T test, p,0.05, compared to vector control group). (C) HMA (10 mM) significantly reduced the whole cell current
through SARS-CoV E protein (*, two-tail unpaired T test, p,0.05, compared to control). (D) same plot for amiloride (10 mM), where the small
difference with the control was not found to be statistically significant (see text).
doi:10.1371/journal.ppat.1000511.g007
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sedimentation equilibrium experiments (unpublished data) suggest
a slightly lower association constant in a monomer-pentamer
equilibrium for full length SARS-CoV E protein, or for a synthetic
ETM spanning residues 7–42 (Ka,10
15), when compared to
ETM8–38 (Ka,10
17) [38]. Thus, the extramembrane residues may
be slightly destabilizing for the SARS-CoV E pentamer.
Conclusion and final remarks
In recent years, several viral proteins have shown membrane
permeabilization properties or ion channel activity, e.g., poliovirus
2B, alphavirus 6 K, HIV-1 Vpu, and influenza virus M2, and have
been named collectively as ‘viroporins’ [52]. However, the
physiological relevance of this activity has only been shown
conclusively for M2, a well known pharmacological target that is
inhibited by AMT for which a detailed structure is available [53–
55]. Electrophysiological data, as well as detailed structural
information is lacking for most of these proteins. We show in the
present work that SARS-CoV E possesses channel activity not only
in vitro, but also when expressed in mammalian cells, and we have
structurally characterized the homo-pentameric transmembrane
domain (ETM) responsible for this activity, when solubilized in
DPC micelles in the absence or presence of small drugs.
Although the precise role of this proposed channel activity is not
known, it is possible that it leads to a subversion of ion homeostasis
in the host cell that could account for the observed attenuation of
E-deleted coronaviruses (see above). For example, in hepatitis B
virus, calcium homeostasis regulation by HBx protein has been
shown to be essential for replication [56]. It is also possible that the
observed pro-apoptotic effect of SARS-CoV E protein in T cells
[57] could be mediated by a disruption of cell ion homeostasis and
membrane depolarization, a general marker of apoptosis [58].
Methods
Peptide synthesis
Isotopically labeled amino acids were derivatized with 9-
fluorenyl-methyloxycarbonyl (FMOC) [59]. The ETM peptide,
corresponding to the transmembrane domain of SARS-CoV E
(residues 8–38), E8TGTLIVNSVLLFLAFVVFLLVTLAIL-
TALR-NH2, was synthesized using standard solid phase FMOC
chemistry (Intavis Respep peptide synthesizer). The peptide was
cleaved from the resin with trifluoroacetic acid (TFA). The
lyophilized peptide was purified by HPLC, as described previously
[21]. Lyophilization was performed in the presence of HCl (at the
molar ratio of 20:1, HCl:peptide) in order to avoid formation of
peptide-TFA adducts; consequently, the TFA band at
,1685 cm
21 was absent in the infrared amide I region (not
shown). Peptide purity was further confirmed by electrospray
ionization (ESI) mass spectrometry. During ETM synthesis,
15N-
labeled amino acids were introduced at positions A22, V24, V25,
and
13C,
15N-labeled amino acids at positions L18, L19 and L21.
NMR sample preparation
Approximately 1.6 mg of lyophilized ETM peptide was solubi-
lized in phosphate-buffered saline (PBS, 10 mM Na2HPO4?-
NaH2PO4) containing 17 mg of DPC (Avanti Polar Lipids), to a
molar ratio of 1:100 (peptide:DPC). Under these conditions,
sedimentation equilibrium studies have shown ETM to be
pentameric [38]. For AMT binding experiments, the NMR sample
was titrated stepwise with AMT (1 amino-adamantane) hydrochlo-
ride powder (Fluka) dissolved in PBS, pH 5.5, up to a final molar
ratio of 1:100:100 (peptide:DPC:AMT). For HMA (5-N,N-
Hexamethylene amiloride, Sigma) and amiloride (amiloride
hydrochloride, Sigma) binding experiments, aliquots of HMA
(solubilized in D6-DMSO, Cambridge Isotopes) or amiloride
(solubilized in water) were added to an empty NMR tube. In both
cases, solvent was removed by lyophilization followed by addition of
ETM/DPC solution to a molar ratio of 1:100:10 (peptide:DPC:-
drug), i.e., ten times less than for AMT (see above). The resulting
mixture was heated to 40uC for 30 min, vortexed and equilibrated
at 30uC for a few hours before collecting NMR spectra.
For the sample preparation in the presence of 16-doxyl stearic
acid (16-DSA), the desired amount of 16-DSA was first dissolved
in methanol. The aliquots of 16-DSA corresponding to 1 mM,
3 mM and 5 mM of 16-DSA in final NMR samples were added to
an empty NMR tube and dried under a stream of dry N2 gas. The
NMR sample containing ETM/DPC was added to the NMR tube
containing the dry 16-DSA and was left to equilibrate for a few
hours. Gadodiamide (OMNISCAN; gadolinium chelated with 2-
[bis[2-[(2-methylamino-2-oxoethyl)-(2-oxido-2-oxoethyl)ami-
no]ethyl]amino]acetate, GE Healthcare) was used from a 0.5 M
stock solution and was diluted to 1.5 mM.
Weakly aligned samples were prepared by soaking a 1 mM
solution of selectively labeled ETM in 100 mM DPC into
polyacrylamide gels. Two different acrylamide concentrations,
4% and 8%, at axial and radial compression, respectively, were
used to independently verify the experimental results. Gels were
prepared from stock containing 36% w/v acrylamide (Bio-Rad
Laboratories) and 0.94 w/v N, N-methylenebisacrylamide (Bio-
Rad Laboratories) which yields an acrylamide/bisacrylamide
molar ratio of 83:1.4% acrylamide gels were cast in 4.2 mm inner
diameter (ID) glass tubes, while 8% gels were cast in a gel chamber
of 5.4 mm ID (New Era Enterprise, Inc). After complete
polymerization, gels were washed in large excess of H2O overnight
to ensure removal of un-reacted components. Gels were then dried
to completeness at 37uC. Peptide solutions were soaked into the
dried gels overnight to ensure complete re-hydration. The 4% gel
was carefully added into a 4.2 mm ID Shigemi tube (Shigemi Co.
Ltd.) and compressed axially using the supplied Shigemi plunger;
the 8% gel was radially compressed into a 4.2 mm ID open-ended
tube using the gel press assembly (New Era Enterprise, Inc), and
secured using the supplied support rod and end gel plug.
NMR spectroscopy
NMR experiments were performed at 30uC using Bruker
Avance-II 700 and 600 NMR spectrometers equipped with
cryogenic probes (Bruker BioSpin). Complete sequence-specific
assignment of backbone
1H
N was achieved using 2D homonuclear
1H
N,
1H
aromatic band-selected NOESY (Fig. S8), 3D
15N resolved
NOESY-HSQC, 3D
13C resolved NOESY-HSQC and 3D
15N
HSQC-NOESY. Intra-monomer NOEs involving both backbone
and side-chain protons were assigned using the same set of 2D and
3D NOESY spectra. Mixing time for all NOESY spectra was set
to 200 ms.
To identify inter-monomer contacts, we constructed a difference
between two 2D
1H
N,
1H
aromatic band-selected NOESY spectra,
acquired with and without
13C decoupling during the t1 chemical
shift evolution period. Based on the reconstructed secondary
structure of ETM, NOEs were identified as inter-monomeric, i.e.,
between
1H covalently bound to L18, L19 or L21 and other
proximal
1H spins, if they could not be explained by intra-
monomer distances. The amplitudes of inter-monomer NOEs
were used to define the corresponding upper limit constraints.
Two sets of HMA
1H resonances were assigned using 2D TOCSY
and 2D NOESY spectra. NOEs between ETM and HMA were
identified by direct comparison of NOESY spectra, measured with
and without the presence of the drug (Fig. S5).
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hydrocarbon phase was verified by the paramagnetic enhance-
ment induced by 16-DSA in the longitudinal
1H
N relaxation of the
six labeled amino acids. The saturation recovery method in a
series of [
1H,
15N]-HSQC experiments with a variable inter-scan
delay was employed. Using two different approaches, the
experimental data obtained was compared to the expected
paramagnetic relaxation enhancement (PRE) from our proposed
pentameric structure (Protocol S1 and Fig. S3). DSS (sodium 2, 2-
dimethyl-2-silapentane-5-sulfonate) was used as the internal
reference for
1H nuclei. The chemical shifts of
13C and
15N
nuclei were calculated from the
1H chemical shifts [60].
1H-
15N
residual dipolar couplings (RDCs) were determined using
TROSY-anti-TROSY spectra. The acquired data was analyzed
with MODULE [61].
Structure reconstruction
The structure of the ETM monomer in DPC micelles was
calculated using the site-specific assignment of
1H,
13C and
15N
resonances and unassigned NOEs as input for the program
CYANA [62,63]. Structure calculations started from 100 random
conformers, using the standard simulated annealing protocol in
CYANA. The statistics of meaningful NOE distance constraints in
the final CYANA cycle (Table S1) showed a high density of
structural constraints per amino acid. Seven cycles of NOE
assignment and structure reconstruction resulted in a bundle of 20
conformers with the average target function values below 0.15.
A symmetrical ETM homo-pentameric structure was recon-
structed (Fig. S1, A–C) starting with a backbone model based on
orientational data from site-specific infrared dichroism (SSID),
which defined helix tilt and rotational pitch angles for residues
L21, A22, F23, and V24 [38]. The ETM a-helix built from NMR
data was superimposed onto the pentamer skeleton to obtain the
full atomic description of the model. This model was subjected to
energy minimization to resolve steric clashes, following which,
inter-helical NOEs (Table S2) were used as constraints in
molecular dynamics (MD) simulations to refine the structure.
Inter-helical NOE constraints were applied one by one; only when
the system reached equilibrium, another constraint was added.
Upon inclusion of all inter-helical constraints, the refined final
model was compatible with both site specific infrared dichroism
and NMR data.
The energy minimization and all the restrained MD simulations
were performed using GROMACS [64] at an atomistic level of
detail, using the OPLS-AA [65] force field. Atomic charges were
assigned on the basis of the default atomic charge values specified
in the OPLS-AA force field. The Van der Waals interactions were
modeled using a cut-off distance of 9.0 A ˚. In the simulation, the
cell temperature was maintained at 298.15 K using the Berendsen
temperature coupling algorithm. The Berendsen pressure coupling
algorithm was applied to maintain the pressure of 1.0 bar. With
backbone positions restrained, each inter-helical distance con-
straint includes a 500 ps simulation, enough for the side chains to
move into a conformation that is constraint allowed. The lumenal
dimensions for the pentameric model were calculated using
HOLE [66] and were visualized using VMD [67].
Docking of AMT and HMA
According to the chemical shift changes observed after addition
of HMA, two ETM pentameric models were obtained. For one
model, residues 8–12 and 17–38 did not change after exposure to
HMA. For the second model, residues 8–30 did not change.
Docking of HMA to these two models was performed using Glide
[68,69] with standard parameters, guided by NOE constraints,
and allowing for HMA flexibility. The binding site was defined in
terms of two concentric cubes: the bounding box, which contains
the center of any acceptable ligand pose, and the enclosing box,
which contains all ligand atoms of an acceptable pose. Upon
completion of each docking calculation, the best docked structure
was chosen using a Glidescore (Gscore) function, a modified and
extended version of the empirically based Chemscore function.
SARS-CoV E construct and transient expression of SARS-
CoV E cDNA in HEK-293 cells
The full-length SARS-CoV E protein gene was cloned into
pIRES-AcGFP1 (Clonetech) vectorby using the restriction enzymes
BglII and PstI. The identity of the insert was confirmed by DNA
sequencing.Ina 35 mmPetridish,1.65 mg ofhumanSARS-CoV E
cDNA was transiently transfected into HEK-293 cells using the
standard calcium phosphate method [70]. The vector pIRES-
AcGFP1 was also transiently transfected in separate experiments as
a control. Another control was the use of untransfected HEK-293
cells. The cells were grown for 36–48 h in a 5% CO2 incubator at
37uC before whole-cell patch clamp recordings.
Electrophysiological recordings and data analysis
Whole-cell current was recorded at room temperature using the
standard patch clamp technique, 48–72 h after transfection. The
bath solution contained the following (mM): 124.0 NaCl, 3.5 KCl,
1.0 NaH2PO4, 26.2 NaHCO3, 1.3 MgSO4, 2.5 CaCl2 and 10.0
D( +)-glucose; gassed with a mixture of 95% O2 and 5% CO2;
pH 7.4, and an osmolarity of 300 mOsmkg
21. The internal
solution (pipette solution) contained the following (mM): 135.0
potassium gluconate, 10.0 KCl, 10.0 Hepes buffer, 0.5 EGTA, 2
Mg-ATP (pH adjusted to 7.3 with KOH; osmolality 275–
285 mOsmkg
21). The voltages were uncorrected for a 29m V
junction potential, and actual voltage is obtained by subtracting
9 mV from the reported values. Whole-cell currents, obtained
under voltage clamp with an Axopatch Multiclamp700B amplifier
(Axon Instruments), were filtered at 1–5 kHz and sampled at 5–
50 kHz. The access resistance Ra (usually less than 20 MV) and
the capacitive transients were not compensated. Stock solutions of
amiloride and HMA (Sigma) at 100 mM were prepared in 50%
DMSO:50% methanol. To determine if the amiloride derivatives
blocked SARS-CoV E protein ion channel conductance in HEK-
293 cells, after ion channel currents were detected, 10 mM of the
drug diluted in bath solution was applied to the cell.
Accession numbers
The accession numbers for the proteins in this paper are SARS-
CoV E, NP_828854; TGEV E, AAZ91440; HCoV-229E E,
NP_073554; MHV E, O72007 and IBV E, P05139.
Supporting Information
Figure S1 Building the ETM a-helical pentameric bundle. The
skeleton of the ETM bundle (A) was based on orientational data
from site specific infrared dichroism [38]. The ETM monomer
built from NMR data was superimposed onto the skeleton (B) to
obtain the full atom description of the model (C). (D) Contact
between L18
1H3
d1 and F23
1H
de (6.03 A ˚) using the initial ETM
helix and (E) after refinement (3.86 A ˚).
Found at: doi:10.1371/journal.ppat.1000511.s001 (3.61 MB TIF)
Figure S2 (A–B) Same as Fig. 1 (A–B), for ETM in the presence
of 10 mM HMA. The 2D NOESY spectrum is not shown due to
large interference from HMA, causing spectral overlap. (C–E)
Same as Fig. 1 (A–C) for ETM in the presence of 100 mM AMT.
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Figure S3 (A) Schematic representation of the ETM channel
surrounded by a DPC micelle that incorporates the paramagnetic
probe 16-DSA. The ratio a, between the volume accessible by the
probe (red) and the total volume occupied by the micelle (blue),
and the distances Rb and R are indicated. (B) Schematic
representation of the ‘‘distance to the surface’’ model for the
calculation of PRE. (C) The same for the ‘‘distance from the
center’’ model (see Protocol S1 for details). (D) Structure and
characteristic dimensions (in A ˚) of the doxyl paramagnetic moiety
of 16-DSA, with the unpaired electron on the oxygen atom
indicated by a dot.
Found at: doi:10.1371/journal.ppat.1000511.s003 (7.61 MB TIF)
Figure S4 (A) Deviation of
1H
N chemical shifts from random
coil values in ETM (black trace). (B) Wavelet analysis of ETM
amide chemical shifts shown in (A) yielded three types of
periodicities as indicated by red/orange regions: the N-terminal,
central and C-terminal regions showed periodicities (1/n) of 1/2.8,
1/6.2 and 1/3.8 residues, where number n indicates the number
of residues required to complete a cycle in chemical shift variation.
In (A), the red trace shows the of 100 mM AMT; the data for
10 mM HMA was similar (not shown).
Found at: doi:10.1371/journal.ppat.1000511.s004 (8.21 MB TIF)
Figure S5 (A) 2D
1H
N,
1H
aromatic band-selected NOESY spectra
of ETM in the presence of 10 mM HMA. The assignment of
ETM and HMA resonances, as well as NOEs between the protein
and HMA (blue lines) are indicated. (B) HMA molecule, with
atoms numbered as in the Protein Data Bank (PDB) structure. (C)
2D
1H
N,
1H
aromatic band-selected NOESY and 2D water gate
NOESY spectra of ETM in the absence (magenta) and presence
(black) of 10 mM HMA. The assignment of two sets of connected
spin systems from HMA bound at the N- and C-termini of ETM
are indicated by green and blue lines, respectively. The assignment
of selected NOEs is indicated.
Found at: doi:10.1371/journal.ppat.1000511.s005 (3.14 MB TIF)
Figure S6 [
1H,
15N]-TROSY of ETM in DPC titrated at the
final concentrations indicated (inserts) with (A) HMA at 30uC (B)
amiloride at 37uC. (C) Same as in (A), but showing only two
conditions: no drug and highest drug concentration tested. In (A)
and (C), the shift for L19 is indicated by an arrow. (D) Same as (C),
but for amiloride instead of HMA. No significant change in peak
position is seen for amiloride at the highest concentration tested.
(E) A fragment of the [
1H,
15N]-TROSY of ETM in DPC,
comprising cross-peaks of Leu 19, Val 24 and Val 25, measured at
30uC; (F) the same at 37uC; (G) the same but in the presence of
HMA, at 30uC. Results using AMT were similar to those with
HMA (not shown).
Found at: doi:10.1371/journal.ppat.1000511.s006 (1.80 MB TIF)
Figure S7 Clustal X sequence alignment of envelope proteins in
coronaviruses, up to the totally conserved Pro residue (P54 in
SARS-CoV E), corresponding to SARSCoV sequences (group 2b,
black), group 1 sequences (blue), group 2 sequences (red) and
group 3 sequences (green). The accession numbers are indicated
next to the common name, on the left. The positions N15 and R38
in the SARS-CoV E sequence are indicated above, and the
residues that are exposed to the lumen of the pore in ETM are
shown with a yellow background. The locations of the two HMA
binding sites in the ETM channel are indicated by a red arrow.
Found at: doi:10.1371/journal.ppat.1000511.s007 (1.86 MB TIF)
Figure S8 Scheme of 2D
1H
N,
1H
aromatic band-selected
NOESY, an experiment suitable for detection of
1H
N,
1H
aromatic
resonances in membrane proteins in the presence of strong
aliphatic resonances of solubilizing detergents. Longitudinal
relaxation acceleration scheme [72] prevents saturation of
longitudinal magnetization of aliphatic spins and water building
up during the mixing period tmix. This magnetization is used to
accelerate relaxation of amide and aromatic protons to steady-
state Boltzmann thermal equilibrium during the inter-scan delay
d1. The radiofrequency pulses on
1H,
15N,
13C are applied at 4.7,
118 and 40 ppm, respectively. Narrow and wide black bars
indicate non-selective p/2 and p rf-pulses applied with the phase x
unless indicated otherwise. Complex shapes on the line marked
1H
indicate the
1H
N,
1H
aromatic band-selective 1.5 ms excitation E-
Burp2 pulses with the phase Q3 and Q4 and cB1=2733 Hz and the
1.8 ms refocussing Re-Burp pulse [73] with the phase Q4 and
cB1=3050 Hz. The center of the excitation of all
1H
N,
1H
aromatic
bandselective pulses is placed at 8.5 ppm. The durations and
strengths of the pulsed magnetic field gradients (PFG) applied
along the z-axis are selected as G1: 500 ms, 80 G/cm; G2: 900 ms,
60 G/cm; G3: 900 ms, 70 G/cm. Two datasets, with and without
13C-composite inversion pulse decoupling pulse are acquired using
the phases Q1=x;Q2=x;Q3=x, y); Qrec=(x, 2x). The quadrature
detection in t1 dimension is achieved by the States-TPPI method
[74] applied to Q1. Subtraction of the datasets results in a 2D
NOESY spectrum containing NOEs stemming from
1H covalently
bound to
13C spins and the other proximal
1H spins.
Found at: doi:10.1371/journal.ppat.1000511.s008 (0.66 MB TIF)
Table S1 Statistics of ETM structure reconstruction, alone or in
the presence of amantadine and HMA.
Found at: doi:10.1371/journal.ppat.1000511.s009 (0.06 MB
DOC)
Table S2 Inter-helical NOEs for ETM derived from difference
2D homonuclear
1H
N,
1H
aromatic band-selected NOESY.
Found at: doi:10.1371/journal.ppat.1000511.s010 (0.04 MB
DOC)
Table S3 Assignment of two forms of HMA bound to the N-
and C-termini of ETM.
Found at: doi:10.1371/journal.ppat.1000511.s011 (0.04 MB
DOC)
Protocol S1 Supplementary methods.
Found at: doi:10.1371/journal.ppat.1000511.s012 (0.02 MB PDF)
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